Adrenocortical Carcinoma
📧 Sign up to get email alerts when something new happens for Adrenocortical Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma [Phase 1]
A Phase 1 clinical trial is evaluating preoperative radiation therapy for participants with resectable recurrent adrenocortical carcinoma an…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating the combination of radiotherapy and pembrolizumab for Adrenocortical Carcinoma, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer [Phase 2]
Phase 2 clinical trial evaluating the addition of cabozantinib to cemiplimab for adolescents and adults with advanced adrenocortical carcino…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001) [NA]
A clinical trial update shows ongoing recruitment for an individualized mRNA neoantigen vaccine, mRNA-0523-L001, to treat several advanced e…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence [Phase 3]
Phase 3 trial update evaluating mitotane with or without cisplatin and etoposide after surgery in patients with Stage I-III adrenocortical c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors [Phase 1]
First-in-human Phase 1 trial update of the antibody-drug conjugate ADCT-701 in patients with neuroendocrine tumors, neuroendocrine carcinoma…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Positioning of Molecular Markers in Clinical Routine for the Management of Patients With Adrenal Cancers/Tumors (COMETE-CARE) [NA]
The COMETE-CARE study is a clinical trial evaluating how molecular markers may guide routine management of adrenal cancers/tumors. The study…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC)
A clinical trial update focusing on optimal methods for assessing disease progression and survival in children and adults with adrenocortica…
-
EMA approval · 2026-03-11EMA Authorised: Lysodren (mitotane) — Esteve Pharmaceuticals, S.A.
EMA authorised marketing of Lysodren (mitotane) by Esteve Pharmaceuticals, S.A. for adrenal cortex neoplasms.
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies [Phase 1, Phase 2]
A Phase 1/2 trial evaluating the combination of anti-CTLA4-NF mAb (BMS-986218), nivolumab, and stereotactic body radiation therapy for metas…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating PDS01ADC with hepatic artery infusion pump and systemic therapy for metastatic colorectal cancer, intrah…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer [Phase 1]
A Phase 1 trial update for DS9051b in advanced or metastatic adrenocortical carcinoma and metastatic castration-resistant prostate cancer, c…
-
CLINICAL_TRIALS trial_result · 2026-01-30Clinical Trial Update: A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma [Phase 1, Phase 2]
Clinical trial update for EO2401 in metastatic adrenocortical carcinoma and malignant pheochromocytoma/paraganglioma reports termination of …
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Phase II Trial of Pembrolizumab Plus Lenvatinib in Advanced Adrenal Cortical Carcinoma [Phase 2]
This clinical trial update reports a Phase II study evaluating the combination of pembrolizumab and lenvatinib in advanced adrenocortical ca…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors [Phase 2]
Status update on a Phase 2 trial of nivolumab plus ipilimumab for advanced rare genitourinary tumors; the study is currently active but not …
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Characterization of the Strasbourg Cohort of Patients With Adrenal Cortex Carcinoma
A Strasbourg-based observational study is recruiting to characterize a cohort of patients with adrenocortical carcinoma.
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: A Phase 1 Study of [225Ac]-FPI-1434 Injection [Phase 1]
A Phase 1 study of [225Ac]-FPI-1434 injection sponsored by Fusion Pharmaceuticals has been terminated.
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Structured Evaluation of adRENal Tumors Discovered Incidentally - Prospectively Investigating the Testing Yield
A completed prospective study evaluating the testing yield for adrenal incidentalomas and adrenocortical carcinoma. Sponsored by University …
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI [Phase 2]
Phase 2 trial evaluating dostarlimab for locally advanced or metastatic dMMR/MSI cancers excluding colorectal and endometrial, across multip…
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)
An ongoing NCI-sponsored observational study to collect tissue samples and characterize the natural history of neuroendocrine neoplasms, inc…
-
CLINICAL_TRIALS trial_result · 2025-10-06Clinical Trial Update: Cemiplimab as Maintenance Treatment for Advanced Adrenocortical Cancer [Phase 2]
A Phase 2 trial is evaluating cemiplimab as maintenance therapy for advanced adrenocortical carcinoma and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma [Phase 2]
Phase 2 clinical trial evaluating surgery with heated intraperitoneal chemotherapy for adrenocortical carcinoma with peritoneal carcinomatos…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: A Prospective, Randomized, Multicenter Clinical Study Comparing Adjuvant Radiotherapy Versus Observation in High-risk Localized Adrenocortical Carcinoma After Surgery. [NA]
A prospective, randomized, multicenter clinical trial to compare adjuvant radiotherapy versus observation after surgery in high-risk localiz…
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: German Adrenocortical Carcinoma Registry
A German registry study for Adrenocortical Carcinoma sponsored by the University of Würzburg is currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: Adrenal Tumors - Pathogenesis and Therapy
This clinical trial update indicates that a study on the pathogenesis and therapy of adrenal tumors is currently recruiting, covering condit…